PROPYLTHIOURACIL

PROPYLTHIOURACIL was reported 2081 times

PROPYLTHIOURACIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL CLAVICULAR AGENESIS 7 0.5833
1 ENDOTHELIOMATOSIS 2 0.5000
2 COCHLEAR INJURY 5 0.4167
3 GOITRE CONGENITAL 11 0.3056
4 FOETAL HAEMOGLOBIN DECREASED 2 0.2222
5 KOILONYCHIA 3 0.1579
6 ANTITHYROID ARTHRITIS SYNDROME 4 0.1481
7 HYPOTHYROIDIC GOITRE 4 0.1481
8 NEONATAL THYROTOXICOSIS 3 0.1250
9 HYPERTENSIVE CARDIOMEGALY 3 0.0938
10 THYROTOXIC CARDIOMYOPATHY 2 0.0909
11 CONGENITAL HYPERTHYROIDISM 2 0.0741
12 PYELECTASIA 2 0.0741
13 ACID FAST STAIN POSITIVE 1 0.0714
14 CAFE AU LAIT SPOTS 7 0.0700
15 ORBITAL HAEMORRHAGE 2 0.0645
16 AMNIOTIC FLUID INDEX INCREASED 1 0.0556
17 APLASIA CUTIS CONGENITA 7 0.0490
18 AORTIC WALL HYPERTROPHY 2 0.0488
19 CONGENITAL HYPOTHYROIDISM 12 0.0465
20 THYROTOXIC CRISIS 52 0.0457
21 IMMATURE RESPIRATORY SYSTEM 7 0.0446
22 ACHOLIA 1 0.0435
23 CONGENITAL GENITAL MALFORMATION FEMALE 2 0.0408
24 METABOLIC MYOPATHY 2 0.0364
25 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 87 0.0352
26 NOONAN SYNDROME 2 0.0351
27 MESENTERIC OCCLUSION 3 0.0330
28 TOXIC GOITRE 2 0.0328
29 KIDNEY DUPLEX 7 0.0292
30 APGAR SCORE ABNORMAL 3 0.0283
31 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 19 0.0259
32 CHOANAL ATRESIA 3 0.0250
33 ANGIOKERATOMA 2 0.0235
34 SECONDARY HYPERTHYROIDISM 2 0.0206
35 PULMONARY RENAL SYNDROME 7 0.0201
36 ANORECTAL STENOSIS 1 0.0189
37 POST PROCEDURAL HYPOTHYROIDISM 4 0.0189
38 INTESTINAL ATRESIA 2 0.0185
39 ANORECTAL MALFORMATION 1 0.0179
40 BASEDOW'S DISEASE 8 0.0170
41 ANAL STENOSIS 9 0.0169
42 UMBILICAL CORD PROLAPSE 2 0.0163
43 BLADDER DISTENSION 2 0.0159
44 MICROSCOPIC POLYANGIITIS 4 0.0154
45 TOXIC NODULAR GOITRE 2 0.0152
46 EAR MALFORMATION 7 0.0151
47 ECTHYMA 6 0.0150
48 WOLFF-PARKINSON-WHITE SYNDROME 7 0.0148
49 MOTOR DEVELOPMENTAL DELAY 8 0.0138
50 ENDOCRINE OPHTHALMOPATHY 12 0.0138
51 THYROTOXIC PERIODIC PARALYSIS 2 0.0137
52 PHARYNGOTONSILLITIS 3 0.0133
53 OBSTRUCTIVE PANCREATITIS 10 0.0131
54 NEONATAL TACHYCARDIA 2 0.0129
55 MICROTIA 4 0.0127
56 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
57 EXOMPHALOS 6 0.0112
58 PHIMOSIS 8 0.0109
59 PYELOCALIECTASIS 10 0.0104
60 CONGENITAL PULMONARY HYPERTENSION 2 0.0104
61 RIGHT ATRIAL ENLARGEMENT 2 0.0101
62 TRI-IODOTHYRONINE INCREASED 4 0.0100
63 PULMONARY VALVE STENOSIS 8 0.0100
64 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 11 0.0098
65 HYPERTHYROIDISM 140 0.0097
66 VENTRICULAR DYSKINESIA 2 0.0096
67 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
68 INFERIOR VENA CAVA DILATATION 2 0.0095
69 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
70 STROKE IN EVOLUTION 2 0.0090
71 ANTI-GAD ANTIBODY POSITIVE 1 0.0089
72 GOITRE 36 0.0088
73 FAMILIAL PERIODIC PARALYSIS 2 0.0088
74 SEPSIS NEONATAL 7 0.0086
75 UROGENITAL FISTULA 2 0.0084
76 SYNDACTYLY 7 0.0084
77 ABDOMINAL WALL CYST 1 0.0082
78 ISCHAEMIC HEPATITIS 11 0.0080
79 CRYPTORCHISM 9 0.0080
80 OESOPHAGEAL ATRESIA 5 0.0080
81 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
82 PURPURA FULMINANS 2 0.0079
83 RIGHT ATRIAL DILATATION 4 0.0079
84 POLYHYDRAMNIOS 8 0.0078
85 HYPEREMESIS GRAVIDARUM 3 0.0078
86 ANTIMITOCHONDRIAL ANTIBODY POSITIVE 1 0.0078
87 SKIN TURGOR DECREASED 3 0.0077
88 PACHYMENINGITIS 2 0.0077
89 LEUKOCYTOCLASTIC VASCULITIS 12 0.0074
90 ATRIAL ENLARGEMENT 2 0.0074
91 CLUBBING 3 0.0074
92 CLINODACTYLY 2 0.0073
93 FOETAL DISORDER 6 0.0072
94 ANASTOMOTIC ULCER HAEMORRHAGE 1 0.0070
95 VASCULITIS NECROTISING 5 0.0070
96 AORTIC ATHEROSCLEROSIS 1 0.0068
97 FOETAL DISTRESS SYNDROME 14 0.0066
98 ANTI-THYROID ANTIBODY POSITIVE 3 0.0066
99 ERYTHROPOIESIS ABNORMAL 2 0.0065
100 THYROXINE FREE INCREASED 4 0.0063
101 RIGHT VENTRICULAR ENLARGEMENT 2 0.0063
102 KLEBSIELLA SEPSIS 7 0.0062
103 ABORTION THREATENED 3 0.0060
104 IODINE ALLERGY 2 0.0060
105 ARRHYTHMIC STORM 2 0.0060
106 CHOLURIA 2 0.0059
107 URTICARIAL VASCULITIS 3 0.0057
108 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
109 DYSMORPHISM 13 0.0055
110 DACRYOSTENOSIS ACQUIRED 7 0.0054
111 LIVER TRANSPLANT 19 0.0052
112 ANAEMIA FOLATE DEFICIENCY 1 0.0052
113 TRACHEOMALACIA 2 0.0051
114 ABNORMAL CLOTTING FACTOR 1 0.0049
115 SYSTEMIC INFECTION 8 0.0048
116 TRACHEO-OESOPHAGEAL FISTULA 3 0.0047
117 EXOPHTHALMOS 10 0.0046
118 THYROXINE INCREASED 3 0.0042
119 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
120 GASTROSCHISIS 2 0.0042
121 CRYOGLOBULINAEMIA 3 0.0042
122 VESTIBULAR DISORDER 5 0.0041
123 TACHYCARDIA FOETAL 2 0.0040
124 HYPOHIDROSIS 2 0.0040
125 WATER INTOXICATION 2 0.0040
126 AORTA HYPOPLASIA 1 0.0038
127 TRI-IODOTHYRONINE DECREASED 2 0.0038
128 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
129 PLACENTAL INSUFFICIENCY 3 0.0037
130 PULMONARY VASCULITIS 2 0.0037
131 HEPATIC NECROSIS 14 0.0037
132 BLOOD IMMUNOGLOBULIN A INCREASED 2 0.0037
133 DEAFNESS NEUROSENSORY 12 0.0036
134 CARDIOGENIC SHOCK 50 0.0035
135 COLLAGEN DISORDER 2 0.0035
136 HAEMANGIOMA 8 0.0035
137 PULMONARY VALVE INCOMPETENCE 5 0.0034
138 ACUTE HEPATIC FAILURE 46 0.0034
139 GRANULOMATOSIS WITH POLYANGIITIS 4 0.0033
140 AGRANULOCYTOSIS 61 0.0033
141 HYDROPS FOETALIS 2 0.0033
142 STAPHYLOCOCCAL SKIN INFECTION 4 0.0033
143 THYROXINE DECREASED 2 0.0032
144 SMALL FOR DATES BABY 16 0.0032
145 HENOCH-SCHONLEIN PURPURA 7 0.0032
146 STOMA SITE HYPERGRANULATION 2 0.0032
147 ACROMEGALY 1 0.0032
148 TROPONIN T INCREASED 4 0.0032
149 GASTROINTESTINAL EROSION 2 0.0031
150 SPEECH DISORDER DEVELOPMENTAL 9 0.0031
151 ANKLE DEFORMITY 1 0.0031
152 CROSS SENSITIVITY REACTION 3 0.0031
153 IGA NEPHROPATHY 5 0.0030
154 THYROIDITIS 9 0.0030
155 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
156 OVERLAP SYNDROME 2 0.0029
157 VENTRICULAR SEPTAL DEFECT 16 0.0028
158 POSTURE ABNORMAL 9 0.0028
159 VASCULITIS 32 0.0027
160 VANISHING BILE DUCT SYNDROME 3 0.0027
161 PULMONARY ALVEOLAR HAEMORRHAGE 15 0.0027
162 ALBUMIN URINE PRESENT 1 0.0026
163 MATERNAL DRUGS AFFECTING FOETUS 20 0.0026
164 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0026
165 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 6 0.0026
166 DILATATION ATRIAL 3 0.0026
167 PNEUMONIA MYCOPLASMAL 2 0.0025
168 BLEEDING TIME PROLONGED 3 0.0025
169 VENTRICULAR ARRHYTHMIA 9 0.0025
170 PANCREATITIS RELAPSING 2 0.0024
171 AORTIC OCCLUSION 1 0.0024
172 BRADYCARDIA FOETAL 2 0.0024
173 MITRAL VALVE PROLAPSE 4 0.0024
174 LOW BIRTH WEIGHT BABY 19 0.0024
175 TWIN PREGNANCY 2 0.0024
176 APGAR SCORE LOW 3 0.0023
177 KIDNEY TRANSPLANT REJECTION 11 0.0023
178 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
179 BLOOD THYROID STIMULATING HORMONE DECREASED 10 0.0022
180 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
181 BONE MARROW DEPRESSION 2 0.0020
182 IDIOSYNCRATIC DRUG REACTION 2 0.0020
183 VENTRICULAR HYPERTROPHY 5 0.0020
184 DILATED CARDIOMYOPATHY 2 0.0020
185 RETINAL ARTERY OCCLUSION 5 0.0020
186 ACUTE PROMYELOCYTIC LEUKAEMIA 2 0.0019
187 CYSTITIS INTERSTITIAL 3 0.0019
188 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 2 0.0018
189 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 2 0.0018
190 COLONIC POLYP 3 0.0018
191 CHOLESTATIC LIVER INJURY 4 0.0018
192 PSYCHOMOTOR RETARDATION 5 0.0018
193 ANENCEPHALY 1 0.0018
194 POLYDACTYLY 2 0.0017
195 PAROTITIS 2 0.0017
196 ALLODYNIA 2 0.0017
197 HEART DISEASE CONGENITAL 6 0.0017
198 LIVE BIRTH 14 0.0017
199 ATRIAL SEPTAL DEFECT 14 0.0017
200 PRETERM PREMATURE RUPTURE OF MEMBRANES 2 0.0017
201 PULMONARY HAEMORRHAGE 13 0.0017
202 SINUS BRADYCARDIA 16 0.0017
203 FOETAL GROWTH RESTRICTION 10 0.0016
204 GLOMERULONEPHRITIS 4 0.0016
205 EJECTION FRACTION ABNORMAL 2 0.0016
206 PREMATURE BABY 49 0.0016
207 HEPATIC ENCEPHALOPATHY 15 0.0016
208 LUPUS NEPHRITIS 3 0.0016
209 BREECH PRESENTATION 2 0.0016
210 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
211 JAUNDICE NEONATAL 3 0.0016
212 HEPATOTOXICITY 35 0.0016
213 PREMATURE DELIVERY 25 0.0016
214 HYPOTHYROIDISM 50 0.0016
215 CONGENITAL ANOMALY 12 0.0015
216 OTITIS MEDIA 5 0.0015
217 TRICUSPID VALVE INCOMPETENCE 12 0.0015
218 MUCOSAL DRYNESS 3 0.0015
219 FOETAL EXPOSURE DURING PREGNANCY 119 0.0015
220 AORTITIS 1 0.0015
221 BILIARY TRACT DISORDER 2 0.0014
222 HYPOSPADIAS 3 0.0014
223 DEATH NEONATAL 2 0.0014
224 ECHOCARDIOGRAM ABNORMAL 2 0.0014
225 DILATATION VENTRICULAR 3 0.0014
226 CIRCULATORY COLLAPSE 24 0.0014
227 AMNIOTIC CAVITY INFECTION 1 0.0014
228 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
229 EXPOSURE DURING PREGNANCY 85 0.0014
230 HEPATITIS FULMINANT 4 0.0013
231 BRAIN HERNIATION 4 0.0013
232 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0013
233 OVERWEIGHT 7 0.0013
234 THYROID MASS 5 0.0013
235 PREMATURE SEPARATION OF PLACENTA 2 0.0013
236 EPIGASTRIC DISCOMFORT 5 0.0013
237 SINUS ARREST 2 0.0013
238 DRUG-INDUCED LIVER INJURY 40 0.0013
239 INTESTINAL ISCHAEMIA 7 0.0013
240 FUNGAEMIA 2 0.0013
241 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
242 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
243 PANNICULITIS 3 0.0012
244 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
245 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
246 HEPATITIS ACUTE 8 0.0012
247 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
248 ANAL ULCER 1 0.0012
249 ACUTE PSYCHOSIS 3 0.0012
250 CAESAREAN SECTION 14 0.0012
251 EXCORIATION 3 0.0012
252 GAZE PALSY 2 0.0012
253 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
254 HYPERBILIRUBINAEMIA 12 0.0012
255 OCULAR ICTERUS 5 0.0012
256 HEPATITIS TOXIC 3 0.0012
257 INGUINAL HERNIA 7 0.0011
258 APLASTIC ANAEMIA 6 0.0011
259 CATATONIA 6 0.0011
260 LIVER TRANSPLANT REJECTION 2 0.0011
261 PNEUMONIA KLEBSIELLA 2 0.0011
262 OTOTOXICITY 2 0.0011
263 HAEMODYNAMIC INSTABILITY 8 0.0010
264 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
265 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
266 OCULAR HYPERTENSION 2 0.0010
267 PURULENCE 2 0.0010
268 APLASIA 2 0.0010
269 RENAL TUBULAR NECROSIS 10 0.0010
270 HYPERAEMIA 2 0.0010
271 ORGANISING PNEUMONIA 5 0.0010
272 CELL DEATH 2 0.0010
273 BLOOD ALBUMIN DECREASED 8 0.0010
274 PROTEIN URINE PRESENT 5 0.0010
275 HEPATITIS CHOLESTATIC 6 0.0010
276 CORONARY ARTERY THROMBOSIS 2 0.0010
277 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
278 NEUTROPENIC SEPSIS 7 0.0010
279 CARDIOMEGALY 12 0.0010
280 DIASTOLIC DYSFUNCTION 3 0.0010
281 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0010
282 THYROID FUNCTION TEST ABNORMAL 4 0.0010
283 MICROCYTIC ANAEMIA 2 0.0010
284 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
285 POLYARTHRITIS 5 0.0009
286 AORTIC VALVE INCOMPETENCE 4 0.0009
287 CARDIAC FAILURE CHRONIC 4 0.0009
288 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
289 NORMAL NEWBORN 5 0.0009
290 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
291 CLOSTRIDIUM TEST POSITIVE 2 0.0009
292 CYTOLYTIC HEPATITIS 3 0.0009
293 AORTIC DILATATION 1 0.0009
294 GRANULOCYTOPENIA 5 0.0009
295 ATRIAL FLUTTER 7 0.0009
296 GRANULOMA 3 0.0009
297 APHTHOUS STOMATITIS 2 0.0009
298 METHAEMOGLOBINAEMIA 2 0.0009
299 HEPATITIS 22 0.0009
300 BILIRUBIN CONJUGATED INCREASED 2 0.0009
301 YELLOW SKIN 4 0.0009
302 MATERNAL EXPOSURE DURING PREGNANCY 76 0.0009
303 PRE-ECLAMPSIA 4 0.0008
304 EOSINOPHIL COUNT DECREASED 2 0.0008
305 PROTHROMBIN TIME PROLONGED 5 0.0008
306 PYODERMA GANGRENOSUM 3 0.0008
307 CHOLESTASIS 16 0.0008
308 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
309 PARADOXICAL DRUG REACTION 3 0.0008
310 MYOPATHY 7 0.0008
311 TACHYARRHYTHMIA 2 0.0008
312 HYPERPARATHYROIDISM SECONDARY 2 0.0008
313 TUMOUR LYSIS SYNDROME 7 0.0008
314 MITRAL VALVE INCOMPETENCE 9 0.0008
315 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
316 DERMATOMYOSITIS 2 0.0008
317 ABORTION MISSED 1 0.0008
318 VENTRICULAR TACHYCARDIA 13 0.0008
319 AORTIC ARTERIOSCLEROSIS 2 0.0008
320 PERIORBITAL OEDEMA 4 0.0008
321 MUCORMYCOSIS 2 0.0008
322 RESPIRATORY ACIDOSIS 3 0.0008
323 HEPATIC FAILURE 23 0.0008
324 HYPERSENSITIVITY VASCULITIS 2 0.0008
325 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
326 PHARYNGOLARYNGEAL PAIN 4 0.0008
327 ENURESIS 3 0.0007
328 EOSINOPHILIA 13 0.0007
329 LARGE INTESTINAL ULCER 2 0.0007
330 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
331 PERIPHERAL ISCHAEMIA 3 0.0007
332 HYDROCEPHALUS 4 0.0007
333 ACUTE RESPIRATORY FAILURE 14 0.0007
334 ACCIDENTAL EXPOSURE 3 0.0007
335 RHABDOMYOLYSIS 30 0.0007
336 AUTOIMMUNE HEPATITIS 5 0.0007
337 ACUTE PULMONARY OEDEMA 4 0.0007
338 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
339 PREMATURE LABOUR 4 0.0007
340 SINUS TACHYCARDIA 10 0.0007
341 HAEMOTHORAX 2 0.0007
342 STRIDOR 2 0.0007
343 LUNG INFILTRATION 6 0.0007
344 CREPITATIONS 2 0.0007
345 CARDIAC ARREST 55 0.0007
346 LUPUS-LIKE SYNDROME 6 0.0007
347 DRUG TOXICITY 9 0.0007
348 LIVER INJURY 16 0.0007
349 THYROID DISORDER 10 0.0006
350 NEPHROGENIC ANAEMIA 3 0.0006
351 BRAIN OEDEMA 8 0.0006
352 JAUNDICE 17 0.0006
353 GESTATIONAL DIABETES 3 0.0006
354 VENTRICULAR HYPOKINESIA 2 0.0006
355 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
356 ABDOMINAL TENDERNESS 3 0.0006
357 HEPATIC ENZYME ABNORMAL 3 0.0006
358 TOXIC SKIN ERUPTION 6 0.0006
359 PRODUCT PHYSICAL ISSUE 12 0.0006
360 COLITIS ISCHAEMIC 4 0.0006
361 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
362 HEPATIC FIBROSIS 2 0.0006
363 FOETAL DEATH 3 0.0006
364 ADRENAL INSUFFICIENCY 7 0.0006
365 AORTIC STENOSIS 2 0.0006
366 HYPERREFLEXIA 2 0.0006
367 ALOPECIA AREATA 1 0.0006
368 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
369 TYPE I HYPERSENSITIVITY 2 0.0006
370 JAUNDICE CHOLESTATIC 2 0.0006
371 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
372 PURPURA 5 0.0006
373 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
374 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
375 CUTANEOUS VASCULITIS 2 0.0005
376 RESPIRATORY DISTRESS 15 0.0005
377 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
378 STREPTOCOCCAL INFECTION 3 0.0005
379 NEPHROPATHY 5 0.0005
380 AUTOIMMUNE THYROIDITIS 2 0.0005
381 CARDIO-RESPIRATORY ARREST 22 0.0005
382 RALES 3 0.0005
383 CARDIOPULMONARY FAILURE 2 0.0005
384 ABDOMINAL WALL HAEMATOMA 1 0.0005
385 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
386 TREATMENT NONCOMPLIANCE 28 0.0005
387 PATENT DUCTUS ARTERIOSUS 2 0.0005
388 TYPE 1 DIABETES MELLITUS 3 0.0005
389 END STAGE RENAL DISEASE 9 0.0005
390 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
391 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
392 LEG AMPUTATION 2 0.0005
393 TEMPERATURE INTOLERANCE 5 0.0005
394 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
395 COAGULOPATHY 8 0.0005
396 CONGESTIVE CARDIOMYOPATHY 2 0.0005
397 HYPERPYREXIA 2 0.0005
398 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
399 HEPATIC PAIN 2 0.0005
400 LUNG NEOPLASM 2 0.0005
401 ANURIA 4 0.0005
402 CARDIAC MURMUR 4 0.0005
403 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
404 TONGUE DISCOLOURATION 2 0.0005
405 PHYSICAL DISABILITY 2 0.0005
406 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
407 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
408 CARDIAC FAILURE ACUTE 3 0.0004
409 RHINITIS ALLERGIC 2 0.0004
410 CHOLECYSTITIS CHRONIC 3 0.0004
411 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
412 MENINGITIS ASEPTIC 2 0.0004
413 DEVELOPMENTAL DELAY 4 0.0004
414 TACHYPNOEA 6 0.0004
415 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
416 IMMUNE THROMBOCYTOPENIA 2 0.0004
417 BRADYCARDIA 23 0.0004
418 HYPERTRANSAMINASAEMIA 3 0.0004
419 RIGHT VENTRICULAR FAILURE 3 0.0004
420 ABORTION SPONTANEOUS 17 0.0004
421 SPINAL COLUMN STENOSIS 2 0.0004
422 FAECAL INCONTINENCE 2 0.0004
423 ENTEROCOCCAL INFECTION 2 0.0004
424 RASH PUSTULAR 3 0.0004
425 VITAMIN D DEFICIENCY 4 0.0004
426 BLOOD BILIRUBIN INCREASED 11 0.0004
427 HEPATOMEGALY 4 0.0004
428 ACUTE MYOCARDIAL INFARCTION 12 0.0004
429 HAEMATOCRIT DECREASED 8 0.0004
430 LEUKOPENIA 20 0.0004
431 MENTAL STATUS CHANGES 11 0.0004
432 ECONOMIC PROBLEM 6 0.0004
433 HAEMOPTYSIS 11 0.0004
434 CACHEXIA 2 0.0004
435 ANOREXIA 5 0.0004
436 STOMACH DISCOMFORT 2 0.0004
437 EJECTION FRACTION DECREASED 6 0.0004
438 HYPOALBUMINAEMIA 3 0.0004
439 APNOEA 3 0.0004
440 ACTINIC KERATOSIS 1 0.0004
441 FAILURE TO THRIVE 2 0.0004
442 DIPLOPIA 10 0.0004
443 TONSILLITIS 2 0.0004
444 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
445 WEIGHT FLUCTUATION 4 0.0004
446 BLOOD LACTIC ACID INCREASED 2 0.0004
447 ANIMAL BITE 1 0.0004
448 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
449 MIOSIS 3 0.0004
450 CARDIAC FAILURE CONGESTIVE 30 0.0004
451 MYASTHENIA GRAVIS 3 0.0004
452 HYPERKALAEMIA 13 0.0004
453 HYPOXIA 13 0.0004
454 PROTEINURIA 7 0.0004
455 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
456 CEREBRAL HAEMORRHAGE 13 0.0004
457 ACUTE CORONARY SYNDROME 3 0.0004
458 EMBOLISM 3 0.0004
459 GASTRIC ULCER HAEMORRHAGE 2 0.0004
460 HEMIPLEGIA 3 0.0004
461 TACHYCARDIA 32 0.0004
462 VENTRICULAR FIBRILLATION 4 0.0004
463 NECROSIS 2 0.0004
464 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
465 FACE OEDEMA 6 0.0004
466 REBOUND EFFECT 4 0.0004
467 HYPOTENSION 71 0.0004
468 FACIAL PARALYSIS 3 0.0004
469 HAEMATURIA 12 0.0004
470 DRUG RESISTANCE 9 0.0004
471 MYOCARDITIS 4 0.0003
472 UNRESPONSIVE TO STIMULI 9 0.0003
473 HERPES VIRUS INFECTION 2 0.0003
474 SKIN WARM 2 0.0003
475 ABORTION 1 0.0003
476 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
477 IMMUNOSUPPRESSION 3 0.0003
478 PANCYTOPENIA 19 0.0003
479 DRUG ERUPTION 6 0.0003
480 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
481 RESPIRATORY RATE INCREASED 3 0.0003
482 MYOSITIS 3 0.0003
483 RENAL IMPAIRMENT 28 0.0003
484 DERMATITIS ACNEIFORM 2 0.0003
485 EXOSTOSIS 3 0.0003
486 NO THERAPEUTIC RESPONSE 4 0.0003
487 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
488 HEPATIC FUNCTION ABNORMAL 12 0.0003
489 ACUTE KIDNEY INJURY 49 0.0003
490 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
491 ABORTION INDUCED 3 0.0003
492 HYPOCALCAEMIA 6 0.0003
493 SPUTUM DISCOLOURED 3 0.0003
494 NEUTROPENIA 43 0.0003
495 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
496 RESPIRATORY FAILURE 23 0.0003
497 TRANSAMINASES INCREASED 7 0.0003
498 HEPATIC CYTOLYSIS 4 0.0003
499 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
500 ATRIAL FIBRILLATION 30 0.0003
501 PLATELET COUNT INCREASED 4 0.0003
502 RENAL FAILURE ACUTE 13 0.0003
503 BODY TEMPERATURE DECREASED 3 0.0003
504 HYPONATRAEMIA 17 0.0003
505 BLOOD UREA INCREASED 5 0.0003
506 PRODUCT TASTE ABNORMAL 4 0.0003
507 SUBARACHNOID HAEMORRHAGE 3 0.0003
508 INITIAL INSOMNIA 3 0.0003
509 EAR DISCOMFORT 3 0.0003
510 ONYCHOCLASIS 2 0.0003
511 PULMONARY OEDEMA 13 0.0003
512 MULTI-ORGAN FAILURE 5 0.0003
513 FORMICATION 2 0.0003
514 ENCEPHALOPATHY 7 0.0003
515 SCRATCH 3 0.0003
516 HAND FRACTURE 2 0.0003
517 HEPATOCELLULAR INJURY 4 0.0003
518 DECREASED ACTIVITY 3 0.0003
519 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
520 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
521 VISUAL FIELD DEFECT 2 0.0003
522 DERMATITIS BULLOUS 2 0.0003
523 LIVER FUNCTION TEST ABNORMAL 8 0.0003
524 OESOPHAGITIS 3 0.0003
525 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
526 CARDIAC FAILURE 22 0.0003
527 BLINDNESS TRANSIENT 2 0.0003
528 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
529 CARDIOMYOPATHY 4 0.0003
530 HYPOPHOSPHATAEMIA 2 0.0003
531 THROMBOCYTOPENIA 30 0.0003
532 MYOCARDIAL ISCHAEMIA 3 0.0003
533 HYPERTHERMIA 2 0.0003
534 RENAL FAILURE CHRONIC 2 0.0003
535 FOOD ALLERGY 2 0.0003
536 ATRIOVENTRICULAR BLOCK 2 0.0003
537 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
538 SPLENOMEGALY 3 0.0003
539 CYANOSIS 4 0.0003
540 SEPTIC SHOCK 11 0.0003
541 FURUNCLE 2 0.0003
542 CHOLECYSTITIS 3 0.0003
543 HYPERLIPIDAEMIA 3 0.0003
544 METABOLIC ACIDOSIS 8 0.0002
545 PREGNANCY 5 0.0002
546 SENSORY LOSS 2 0.0002
547 PALPITATIONS 29 0.0002
548 ESCHERICHIA INFECTION 2 0.0002
549 OSTEOPOROSIS 10 0.0002
550 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
551 VIRAL INFECTION 8 0.0002
552 FUNGAL INFECTION 8 0.0002
553 ASCITES 7 0.0002
554 MUSCULOSKELETAL DISCOMFORT 4 0.0002
555 HIATUS HERNIA 3 0.0002
556 PRURITUS GENERALISED 5 0.0002
557 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
558 MENTAL DISORDER 10 0.0002
559 PRODUCT PRESCRIBING ISSUE 5 0.0002
560 DEAFNESS 6 0.0002
561 SPINAL OSTEOARTHRITIS 2 0.0002
562 EMOTIONAL DISORDER 7 0.0002
563 PRODUCT COMMUNICATION ISSUE 2 0.0002
564 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
565 WRONG DRUG ADMINISTERED 2 0.0002
566 ISCHAEMIC STROKE 4 0.0002
567 THROMBOSIS 18 0.0002
568 CHROMATURIA 5 0.0002
569 HEART RATE IRREGULAR 5 0.0002
570 PERIPHERAL COLDNESS 3 0.0002
571 PNEUMONIA BACTERIAL 2 0.0002
572 UROSEPSIS 2 0.0002
573 FEELING COLD 6 0.0002
574 APHONIA 3 0.0002
575 DEFORMITY 2 0.0002
576 FLANK PAIN 2 0.0002
577 PHOTOPHOBIA 4 0.0002
578 ARTERIOSCLEROSIS 2 0.0002
579 BRONCHOSPASM 3 0.0002
580 IMPAIRED QUALITY OF LIFE 3 0.0002
581 PULMONARY FIBROSIS 4 0.0002
582 AFFECT LABILITY 2 0.0002
583 ATELECTASIS 2 0.0002
584 HYPOGLYCAEMIA 10 0.0002
585 PRESYNCOPE 5 0.0002
586 AUTOIMMUNE DISORDER 2 0.0002
587 CEREBRAL INFARCTION 5 0.0002
588 ANAEMIA 39 0.0002
589 ABASIA 5 0.0002
590 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
591 INABILITY TO AFFORD MEDICATION 2 0.0002
592 IMMUNODEFICIENCY 3 0.0002
593 PNEUMONIA ASPIRATION 5 0.0002
594 DEEP VEIN THROMBOSIS 13 0.0002
595 EMPHYSEMA 2 0.0002
596 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
597 PLEURAL EFFUSION 12 0.0002
598 DRUG DISPENSING ERROR 3 0.0002
599 AMMONIA INCREASED 1 0.0002
600 RENAL FAILURE 26 0.0002
601 COGNITIVE DISORDER 9 0.0002
602 ACUTE MYELOID LEUKAEMIA 3 0.0002
603 THERAPY PARTIAL RESPONDER 3 0.0002
604 RESPIRATORY TRACT INFECTION 5 0.0002
605 TENDERNESS 2 0.0002
606 HEART RATE INCREASED 19 0.0002
607 PETECHIAE 2 0.0002
608 ANHEDONIA 5 0.0002
609 DISEASE RECURRENCE 9 0.0002
610 PNEUMOTHORAX 3 0.0002
611 FULL BLOOD COUNT ABNORMAL 2 0.0002
612 BODY HEIGHT DECREASED 2 0.0002
613 PRODUCT USE ISSUE 35 0.0002
614 INTERSTITIAL LUNG DISEASE 9 0.0002
615 CHRONIC KIDNEY DISEASE 14 0.0002
616 PALLOR 5 0.0002
617 GASTROINTESTINAL PAIN 2 0.0002
618 FOOT DEFORMITY 2 0.0002
619 LIVER DISORDER 8 0.0002
620 STEVENS-JOHNSON SYNDROME 4 0.0002
621 RASH MACULO-PAPULAR 4 0.0002
622 HYPERTENSIVE CRISIS 2 0.0002
623 CHILLS 21 0.0002
624 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
625 NEPHROPATHY TOXIC 2 0.0002
626 THERAPY NON-RESPONDER 8 0.0002
627 PANCREATITIS ACUTE 4 0.0002
628 PYREXIA 61 0.0002
629 DERMATITIS CONTACT 2 0.0002
630 CHOLECYSTECTOMY 2 0.0002
631 OFF LABEL USE 153 0.0002
632 TINNITUS 8 0.0002
633 PARANOIA 3 0.0002
634 SHOCK 4 0.0002
635 ECZEMA 9 0.0002
636 POST PROCEDURAL HAEMORRHAGE 2 0.0002
637 NEUTROPHIL COUNT DECREASED 7 0.0002
638 DYSSTASIA 5 0.0002
639 HEART RATE DECREASED 6 0.0002
640 ARRHYTHMIA 8 0.0002
641 THIRST 3 0.0002
642 WRIST FRACTURE 2 0.0002
643 BLOOD POTASSIUM DECREASED 5 0.0002
644 HYPERGLYCAEMIA 6 0.0002
645 DRUG INTERACTION 26 0.0002
646 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
647 SMALL INTESTINAL OBSTRUCTION 2 0.0002
648 HEPATIC STEATOSIS 3 0.0002
649 MIDDLE INSOMNIA 3 0.0002
650 HEPATIC CIRRHOSIS 3 0.0002
651 BLOOD SODIUM DECREASED 3 0.0002
652 GASTRIC ULCER 3 0.0002
653 CARDIOVASCULAR DISORDER 4 0.0002
654 FEELING JITTERY 3 0.0002
655 TREATMENT FAILURE 13 0.0002
656 INFLAMMATION 8 0.0002
657 CONDITION AGGRAVATED 47 0.0002
658 EAR PAIN 3 0.0002
659 BLOOD CREATININE INCREASED 10 0.0002
660 CHOLELITHIASIS 5 0.0002
661 SEPSIS 17 0.0002
662 WHEEZING 9 0.0002
663 PULMONARY CONGESTION 2 0.0002
664 STAPHYLOCOCCAL INFECTION 5 0.0002
665 ADVERSE REACTION 2 0.0002
666 FEBRILE NEUTROPENIA 10 0.0002
667 BLOOD PRESSURE DECREASED 10 0.0002
668 DRUG INEFFECTIVE 198 0.0002
669 HAIR TEXTURE ABNORMAL 2 0.0001
670 QUALITY OF LIFE DECREASED 2 0.0001
671 EPISTAXIS 11 0.0001
672 ABNORMAL LOSS OF WEIGHT 1 0.0001
673 HAEMOGLOBIN DECREASED 15 0.0001
674 SKIN LESION 4 0.0001
675 RESPIRATORY ARREST 4 0.0001
676 TREMOR 24 0.0001
677 DELIRIUM 5 0.0001
678 PULMONARY HYPERTENSION 3 0.0001
679 MEDICATION ERROR 8 0.0001
680 DERMATITIS 3 0.0001
681 DEMENTIA 4 0.0001
682 SKIN REACTION 2 0.0001
683 ASTHMA 16 0.0001
684 MYALGIA 24 0.0001
685 EATING DISORDER 3 0.0001
686 OROPHARYNGEAL PAIN 13 0.0001
687 OEDEMA PERIPHERAL 17 0.0001
688 HYPOACUSIS 6 0.0001
689 VAGINAL HAEMORRHAGE 6 0.0001
690 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
691 GASTROENTERITIS 2 0.0001
692 ANGIOEDEMA 6 0.0001
693 PSYCHOTIC DISORDER 4 0.0001
694 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
695 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
696 RASH PAPULAR 3 0.0001
697 RESPIRATORY DISORDER 4 0.0001
698 DYSARTHRIA 5 0.0001
699 WEIGHT DECREASED 37 0.0001
700 APHASIA 4 0.0001
701 APPLICATION SITE PRURITUS 3 0.0001
702 AORTIC ANEURYSM 1 0.0001
703 PERICARDIAL EFFUSION 3 0.0001
704 LYMPHOMA 2 0.0001
705 MUSCULOSKELETAL CHEST PAIN 2 0.0001
706 ANKLE FRACTURE 2 0.0001
707 INJURY 9 0.0001
708 BONE DENSITY DECREASED 4 0.0001
709 AFFECTIVE DISORDER 1 0.0001
710 PRODUCT USE COMPLAINT 2 0.0001
711 DYSPHAGIA 12 0.0001
712 COMA 6 0.0001
713 RESPIRATORY TRACT CONGESTION 2 0.0001
714 OBESITY 2 0.0001
715 RASH ERYTHEMATOUS 6 0.0001
716 INTENTIONAL OVERDOSE 8 0.0001
717 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
718 EYE PAIN 7 0.0001
719 EMOTIONAL DISTRESS 15 0.0001
720 NEURALGIA 3 0.0001
721 BACK DISORDER 2 0.0001
722 ABNORMAL FAECES 1 0.0001
723 EYE DISORDER 4 0.0001
724 VOMITING 57 0.0001
725 VISUAL ACUITY REDUCED 4 0.0001
726 AGEUSIA 3 0.0001
727 POLLAKIURIA 5 0.0001
728 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
729 CHEST PAIN 22 0.0001
730 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
731 HAEMATEMESIS 3 0.0001
732 SCAR 2 0.0001
733 HYPERHIDROSIS 15 0.0001
734 RECTAL HAEMORRHAGE 5 0.0001
735 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
736 VERTIGO 7 0.0001
737 DISCOMFORT 7 0.0001
738 MUCOSAL INFLAMMATION 3 0.0001
739 SPEECH DISORDER 6 0.0001
740 ARTHRITIS 9 0.0001
741 PNEUMONIA 37 0.0001
742 CONTUSION 11 0.0001
743 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
744 HEAD DISCOMFORT 2 0.0001
745 GALLBLADDER DISORDER 2 0.0001
746 GOUT 2 0.0001
747 NAUSEA 88 0.0001
748 ANAL INCONTINENCE 1 0.0001
749 PNEUMONITIS 3 0.0001
750 C-REACTIVE PROTEIN INCREASED 4 0.0001
751 SKIN DISCOLOURATION 5 0.0001
752 HYPOKALAEMIA 5 0.0001
753 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
754 CHEST DISCOMFORT 11 0.0001
755 BLISTER 6 0.0001
756 OXYGEN SATURATION DECREASED 6 0.0001
757 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
758 FOOT FRACTURE 2 0.0001
759 OCULAR HYPERAEMIA 5 0.0001
760 BLOOD URINE PRESENT 2 0.0001
761 RED BLOOD CELL COUNT DECREASED 3 0.0001
762 MIGRAINE 10 0.0001
763 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
764 POST PROCEDURAL COMPLICATION 2 0.0001
765 DRUG PRESCRIBING ERROR 2 0.0001
766 DRUG INTOLERANCE 10 0.0001
767 ERUCTATION 2 0.0001
768 INTENTIONAL PRODUCT MISUSE 9 0.0001
769 DYSPHONIA 6 0.0001
770 SKIN FISSURES 2 0.0001
771 NASAL CONGESTION 6 0.0001
772 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
773 URINARY INCONTINENCE 3 0.0001
774 DISABILITY 2 0.0001
775 SINUS DISORDER 2 0.0001
776 DISORIENTATION 4 0.0001
777 SPINAL FRACTURE 2 0.0001
778 LACRIMATION INCREASED 3 0.0001
779 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
780 CORONARY ARTERY DISEASE 3 0.0001
781 PRODUCT ADMINISTRATION ERROR 2 0.0001
782 ABDOMINAL PAIN 23 0.0001
783 DYSKINESIA 4 0.0001
784 BONE MARROW FAILURE 2 0.0001
785 BODY TEMPERATURE INCREASED 2 0.0001
786 INFLUENZA LIKE ILLNESS 8 0.0001
787 TOOTH LOSS 2 0.0001
788 AGITATION 7 0.0001
789 WITHDRAWAL SYNDROME 4 0.0001
790 MOUTH ULCERATION 2 0.0001
791 HEAD INJURY 3 0.0001
792 BRONCHITIS 7 0.0001
793 OSTEOARTHRITIS 4 0.0001
794 PLATELET COUNT DECREASED 10 0.0001
795 RETCHING 2 0.0001
796 IMPAIRED WORK ABILITY 2 0.0001
797 NIGHT SWEATS 3 0.0001
798 DISEASE PROGRESSION 11 0.0001
799 POOR QUALITY SLEEP 2 0.0001
800 DISTURBANCE IN ATTENTION 5 0.0001
801 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
802 OEDEMA 5 0.0001
803 ANXIETY 26 0.0001
804 MELAENA 2 0.0001
805 ASTHENIA 34 0.0001
806 INSOMNIA 24 0.0001
807 SKIN DISORDER 3 0.0001
808 GAIT INABILITY 3 0.0001
809 TYPE 2 DIABETES MELLITUS 3 0.0001
810 CEREBROVASCULAR ACCIDENT 15 0.0001
811 HEPATIC ENZYME INCREASED 6 0.0001
812 MUSCULAR WEAKNESS 10 0.0001
813 HERPES ZOSTER 5 0.0001
814 LETHARGY 5 0.0001
815 MUSCLE TWITCHING 2 0.0001
816 NIGHTMARE 3 0.0001
817 ARTHRALGIA 36 0.0001
818 DRY MOUTH 7 0.0001
819 BURNING SENSATION 6 0.0001
820 SWELLING 8 0.0001
821 BLOOD PRESSURE INCREASED 13 0.0001
822 HYPERTENSION 18 0.0001
823 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
824 DIZZINESS 42 0.0001
825 MULTIPLE SCLEROSIS 4 0.0001
826 BLOOD PRESSURE FLUCTUATION 2 0.0001
827 LOCALISED INFECTION 2 0.0001
828 ABDOMINAL PAIN UPPER 17 0.0001
829 THERAPEUTIC RESPONSE DECREASED 5 0.0001
830 SUICIDE ATTEMPT 5 0.0001
831 RESTLESSNESS 3 0.0001
832 MUSCLE SPASMS 15 0.0001
833 PRURITUS 31 0.0001
834 SYNCOPE 8 0.0001
835 DYSPNOEA EXERTIONAL 3 0.0001
836 ABDOMINAL PAIN LOWER 2 0.0001
837 GAIT DISTURBANCE 15 0.0001
838 LOSS OF CONSCIOUSNESS 10 0.0001
839 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
840 DYSPNOEA 44 0.0001
841 URTICARIA 13 0.0001
842 DIARRHOEA 50 0.0001
843 RASH GENERALISED 2 0.0001
844 ALOPECIA 15 0.0001
845 SEDATION 2 0.0001
846 MUSCULOSKELETAL PAIN 4 0.0001
847 APPLICATION SITE ERYTHEMA 2 0.0001
848 GASTRITIS 2 0.0001
849 INFECTION 11 0.0001
850 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
851 FATIGUE 59 0.0001
852 COUGH 21 0.0001
853 DEPRESSION 17 0.0001
854 JOINT SWELLING 9 0.0001
855 CONFUSIONAL STATE 12 0.0001
856 THROAT TIGHTNESS 2 0.0001
857 VISION BLURRED 10 0.0001
858 HAEMATOCHEZIA 4 0.0001
859 TOXICITY TO VARIOUS AGENTS 12 0.0001
860 DYSPEPSIA 7 0.0001
861 RASH 31 0.0001
862 INTENTIONAL DOSE OMISSION 2 0.0001
863 INCORRECT DOSE ADMINISTERED 16 0.0001
864 CONVULSION 4 0.0001
865 SOMNOLENCE 14 0.0001
866 EYE IRRITATION 4 0.0001
867 ANOSMIA 1 0.0001
868 APATHY 1 0.0001
869 MUSCULOSKELETAL STIFFNESS 6 0.0001
870 DEHYDRATION 9 0.0001
871 ABDOMINAL DISTENSION 7 0.0001
872 HALLUCINATION 5 0.0001
873 HOT FLUSH 5 0.0001
874 UNEVALUABLE EVENT 5 0.0001
875 ILL-DEFINED DISORDER 4 0.0001
876 SKIN IRRITATION 3 0.0001
877 HEADACHE 41 0.0001
878 PAIN 40 0.0001
879 LIMB DISCOMFORT 2 0.0001
880 DECREASED APPETITE 15 0.0001
881 URINARY TRACT INFECTION 11 0.0001
882 NERVOUS SYSTEM DISORDER 2 0.0001
883 PULMONARY EMBOLISM 6 0.0001
884 PRODUCTIVE COUGH 3 0.0001
885 MOOD SWINGS 2 0.0001
886 MOVEMENT DISORDER 2 0.0001
887 SWELLING FACE 4 0.0001
888 LUNG DISORDER 3 0.0001
889 IMPAIRED HEALING 2 0.0001
890 OSTEONECROSIS 2 0.0001
891 SEIZURE 7 0.0001
892 EXPIRED PRODUCT ADMINISTERED 2 0.0001
893 SKIN EXFOLIATION 5 0.0001
894 HYPERSENSITIVITY 11 0.0001
895 SINUSITIS 6 0.0001
896 FEELING ABNORMAL 14 0.0001
897 ILLNESS 6 0.0001
898 BALANCE DISORDER 5 0.0001
899 DEVICE USE ERROR 2 0.0001
900 NERVOUSNESS 3 0.0001
901 PARAESTHESIA 9 0.0001
902 RASH MACULAR 2 0.0001
903 DERMATITIS ATOPIC 3 0.0001
904 LYMPHADENOPATHY 2 0.0001
905 BACK PAIN 13 0.0001
906 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
907 GASTROINTESTINAL DISORDER 5 0.0001
908 MOBILITY DECREASED 4 0.0001
909 RASH PRURITIC 3 0.0001
910 SUICIDAL IDEATION 5 0.0001
911 FALL 18 0.0001
912 HYPOAESTHESIA 8 0.0001
913 MALAISE 23 0.0001
914 PRODUCT SUBSTITUTION ISSUE 3 0.0001
915 COVID-19 9 0.0001
916 SURGERY 3 0.0001
917 CONSTIPATION 11 0.0001
918 INJECTION SITE BRUISING 4 0.0001
919 NASOPHARYNGITIS 9 0.0000
920 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
921 DRUG DOSE OMISSION 8 0.0000
922 RHINORRHOEA 3 0.0000
923 AMNESIA 3 0.0000
924 PRODUCT DOSE OMISSION 3 0.0000
925 PERIPHERAL SWELLING 7 0.0000
926 INFLUENZA 5 0.0000
927 THROAT IRRITATION 2 0.0000
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
929 ERYTHEMA 9 0.0000
930 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
931 NEPHROLITHIASIS 2 0.0000
932 INJECTION SITE REACTION 3 0.0000
933 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
934 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
935 VISUAL IMPAIRMENT 5 0.0000
936 DRY EYE 2 0.0000
937 AGGRESSION 2 0.0000
938 CELLULITIS 2 0.0000
939 FLUSHING 4 0.0000
940 FLUID RETENTION 2 0.0000
941 ANAPHYLACTIC SHOCK 1 0.0000
942 HAEMORRHAGE 4 0.0000
943 PANCREATITIS 2 0.0000
944 DEPRESSED MOOD 2 0.0000
945 PROSTATE CANCER 3 0.0000
946 DRUG EFFECT DECREASED 2 0.0000
947 DEPENDENCE 2 0.0000
948 MEMORY IMPAIRMENT 5 0.0000
949 ABNORMAL DREAMS 1 0.0000
950 ANAPHYLACTIC REACTION 2 0.0000
951 NECK PAIN 2 0.0000
952 WEIGHT INCREASED 8 0.0000
953 FLATULENCE 2 0.0000
954 RHEUMATOID ARTHRITIS 4 0.0000
955 ANGINA PECTORIS 1 0.0000
956 MYOCARDIAL INFARCTION 6 0.0000
957 PRODUCT DOSE OMISSION ISSUE 10 0.0000
958 ADVERSE DRUG REACTION 3 0.0000
959 STOMATITIS 2 0.0000
960 FEELING HOT 2 0.0000
961 ADVERSE EVENT 3 0.0000
962 OVERDOSE 7 0.0000
963 INJECTION SITE ERYTHEMA 4 0.0000
964 BLOOD GLUCOSE INCREASED 6 0.0000
965 NEUROPATHY PERIPHERAL 3 0.0000
966 INFUSION RELATED REACTION 2 0.0000
967 DRY SKIN 4 0.0000
968 INJECTION SITE PRURITUS 2 0.0000
969 ABDOMINAL DISCOMFORT 5 0.0000
970 ANGER 1 0.0000
971 PRODUCT QUALITY ISSUE 4 0.0000
972 DEVICE MALFUNCTION 2 0.0000
973 SLEEP DISORDER 2 0.0000
974 SKIN BURNING SENSATION 2 0.0000
975 NO ADVERSE EVENT 5 0.0000
976 UNDERDOSE 2 0.0000
977 DIABETES MELLITUS 2 0.0000
978 INJECTION SITE SWELLING 2 0.0000
979 HOSPITALISATION 4 0.0000
980 ABNORMAL BEHAVIOUR 1 0.0000
981 INJECTION SITE HAEMORRHAGE 2 0.0000
982 DRUG DEPENDENCE 4 0.0000
983 DEATH 21 0.0000
984 PSORIASIS 3 0.0000
985 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
986 BREAST CANCER 2 0.0000
987 INJECTION SITE PAIN 6 0.0000
988 PAIN IN EXTREMITY 5 0.0000
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
990 ACNE 1 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000